Magee Thomson Investment Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$14.6M Sell
117,400
-27,400
-19% -$3.28M 5.64% 4
2016
Q4
$16.8M Sell
144,800
-4,800
-3% -$535K 5.82% 2
2016
Q3
$15.6M Buy
149,600
+35,370
+31% +$3.83M 5.17% 9
2016
Q2
$11.3M Sell
114,230
-12,100
-10% -$1.25M 3.94% 11
2016
Q1
$12.6M Sell
126,330
-2,450
-2% -$252K 3.99% 10
2015
Q4
$15.4M Buy
128,780
+1,350
+1% +$156K 4.24% 8
2015
Q3
$13.8M Buy
127,430
+7,180
+6% +$891K 4.25% 6
2015
Q2
$13.9M Buy
120,250
+7,550
+7% +$863K 4.04% 7
2015
Q1
$13M Buy
112,700
+9,150
+9% +$1.09M 3.14% 17
2014
Q4
$11.6M Buy
+103,550
New +$10.9M 2.88% 20

Other funds holding CELG

Magee Thomson Investment Partners's CELG Position: Q1 2017 in Review

Magee Thomson Investment Partners reduced its Celgene Corp (CELG) stake by 19% in Q1 2017, selling an estimated $3.28M and leaving 117,400 shares worth $14.6M. The position accounts for 5.64% of the portfolio, ranked #4.

Magee Thomson Investment Partners first reported a position in CELG in Q4 2014 and has held it in 10 quarters since. The position peaked at $16.8M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Magee Thomson Investment Partners held 117,400 shares of Celgene Corp worth $14.6M as of Q1 2017.
  • Magee Thomson Investment Partners sold 27,400 Celgene Corp shares in Q1 2017, an estimated $3.28M.
  • Celgene Corp made up 5.64% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #4 holding.
  • Magee Thomson Investment Partners first reported a position in Celgene Corp in Q4 2014 and has held it in 10 quarters since.
  • Magee Thomson Investment Partners's Celgene Corp position peaked at $16.8M in Q4 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.